Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients	Alcon	Completed	Travoprost 0.004% / Timolol	3	C-12-008	KKESH
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma	Novartis	Terminated	QAW039/Fevipiprant	3	CQAW039A2315	KFMC
A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma	Novartis	Terminated	QAW039/Fevipiprant	3	CQAW039A2315	KFMC
A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants	Novartis	Completed	Everolimus + reduced tacrolimus VS.Tacrolimus	3	CRAD001H2307	KFSH & RC-R
“MERS-CoV Infection Treated with a Combination of Lopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-Blind Randomized Trial (MIRACLE Trial)”	KAIMRC	Completed	Kaletra	3	RC15/142/R	NGHA-R
"RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity"	Novartis	Completed	Ranibizumab	3	CRFB002H2301E1	KFSH & RC-R
Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection	Janssen-Cilag International NV	Completed	TMC435 (simeprevir)	3b	TMC435HPC3014	KFSH & RC-R
An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction	Roche	Terminated	Trastuzumab SC	3b	ML28851	KKUH (Closed)
An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women	"Vifor Pharma "	Terminated	Ferrous Sulphate + Ferinject	3	FER-ASAP-2009-01	KFSH & RC-R
A RANDOMIZED, PARTIALLY-BLIND, PLACEBO-CONTROLLED, PILOT, DOSE-RANGING STUDY TO ASSESS THE EFFECT OF GWP42003 ON LIVER FAT LEVELS IN SUBJECT WITH FATTY LIVER DISEASE	GW	Rejected	Cannabidiol	2a	GWZMD1188	KKUH